Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
37971
CAS Number:
85801-02-1
Indometacin farnesil
Purity:
≥ 98% (HPLC)
Documents
$319.98 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Indometacin farnesil is a potent derivative of the non-steroidal anti-inflammatory drug (NSAID) indometacin, designed to enhance its therapeutic efficacy while minimizing side effects. This compound exhibits significant anti-inflammatory and analgesic properties, making it a valuable asset in the treatment of various inflammatory conditions. Its unique farnesyl group contributes to improved bioavailability and cellular uptake, which can lead to enhanced therapeutic outcomes. Researchers and industry professionals have explored its applications in pain management, particularly in conditions such as arthritis and other musculoskeletal disorders.

Moreover, Indometacin farnesil has shown promise in cancer research, where its ability to inhibit specific signaling pathways may offer new avenues for therapeutic interventions. The compound's favorable pharmacokinetic profile and targeted action make it an attractive candidate for further development in both pharmaceutical and clinical settings. With its dual role in inflammation and potential anticancer activity, Indometacin farnesil stands out as a versatile compound for researchers and healthcare professionals seeking innovative solutions in treatment strategies.

CAS Number
85801-02-1
Purity
≥ 98% (HPLC)
Molecular Formula
C34H40ClNO4
Molecular Weight
562.15
MDL Number
MFCD00870661
PubChem ID
3716
Appearance
Light yellow to yellow to orange clear liquid
Conditions
Store at 2 - 8 °C
General Information
CAS Number
85801-02-1
Purity
≥ 98% (HPLC)
Molecular Formula
C34H40ClNO4
Molecular Weight
562.15
MDL Number
MFCD00870661
PubChem ID
3716
Appearance
Light yellow to yellow to orange clear liquid
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Indometacin farnesil is widely utilized in research focused on:

  • Pharmaceutical Development: This compound is explored for its potential anti-inflammatory and analgesic properties, making it a candidate for developing new pain relief medications.
  • Cancer Research: Studies are investigating its effectiveness in inhibiting tumor growth, particularly in certain types of cancers, offering hope for innovative treatment options.
  • Drug Delivery Systems: Indometacin farnesil can be incorporated into advanced drug delivery systems, enhancing the bioavailability and targeted delivery of therapeutic agents.
  • Neuroscience: Research is being conducted on its effects on neurological disorders, with the aim of developing treatments that can mitigate symptoms or slow disease progression.
  • Veterinary Medicine: The compound is also being evaluated for its potential use in treating inflammatory conditions in animals, providing veterinarians with new therapeutic options.

Citations